Note: Ingredients listed on restricted chemical lists
EC/CAS
203-905-0/111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
≤5
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.001 0.06%≤C<0.6 ≥0.0015%
General Information
Revision date
2022-12-09
Product name
Artisan Clearing Solution
1.2.1 Relevant identified uses
Laboratory use Container type: Bottle AR309 // Artisan Clearing Solution // Artisan Clearing Solution // 5x100 mL AR314 // Artisan Maintenance Reagent // Artisan Maintenance Kit // 100 mL
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
Agilent Technologies, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
sds@agilent.com
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
Contains reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H- isothiazol-3-one (3:1). May produce an allergic reaction. Safety data sheet available on request.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
